Screening of microsatellite markers in penile cancer reveals differences between metastatic and nonmetastatic carcinomas

Modern Pathology

Volumn 20, Issue 10, 2007, Pages 1069-1077

  Poetsch, Micaela ^a,b   Schuart, Ben John ^a   Schwesinger, Günther ^a   Kleist, Britta ^a   Protzel, Chris ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

HPV; LOH; Metastasis; Microsatellite marker; Penile carcinoma

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 2Q; CHROMOSOME 6P; CHROMOSOME 8Q; CHROMOSOME 9P; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; LYMPH NODE METASTASIS; MALE; METASTASIS; MICROSATELLITE MARKER; PENIS CANCER; PRIORITY JOURNAL; PROGNOSIS; SKIN METASTASIS; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; PENILE NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 34548761447     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800931     Document Type: Article

References (44)

1. Doehn C, Baumgartel M, Jocham D. Surgical therapy of penis carcinoma. Urologe 2001;A40:303-307.
2. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001;88:473-483.
3. Ficarra V, Martignoni G, Maffei N, et al. Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis. Int Urol Nephrol 2002;34:245-250.
4. Solsona E, Iborra I, Rubio J, et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001;165:1506-1509.
5. Lopes A, Hidalgo GS, Kowalski LP, et al. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 1996;156:1637-1642.
6. Emerson RE, Ulbright TM, Eble JN, et al. Predicting cancer progression in patients with penile squamous cell carcinoma: the importance of depth of invasion and vascular invasion. Mod Pathol 2001;14:963-968.
7. Villavicencio H, Rubio-Briones J, Regalado R, et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997;32:442-447.
8. Martins AC, Faria SM, Cologna AJ, et al. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002;167:89-92.
9. Lopes A, Bezerra AL, Pinto CA, et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002;168:81-86.
10. Alves G, Heller A, Fiedler W, et al. Genetic imbalances in 26 cases of penile squamous cell carcinoma. Genes Chromosom Cancer 2001;31:48-53.
11. Humbey O, Cairey-Remonnay S, Guerrini JS, et al. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer 2003;39:684-690.
12. Eble JN, Sauter G, Epstein JI, et al. Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours. IARC Press: Lyon, 2004, pp 280-290.
13. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. Wiley-Liss: New York, 2002.
14. Poetsch M, Dittberner T, Woenckhaus C. PTEN/MMAC1 in malignant melanoma and its importance for tumour progression. Cancer Genet Cytogenet 2001;125:21-26.
15. Poetsch M, Zimmermann A, Wolf E, et al. Loss of heterozygosity occurs predominantly, but not exclusively in the epithelial compartment of pleomorphic adenoma. Neoplasia 2005;7:688-695.
16. Husnjak K, Grce M, Magdic L, et al. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000;88:125-134.
17. Riethdorf S, Riethdorf L, Milde-Langosch K, et al. Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Arch 2000;437:491-500.
18. Ornellas AA, Ornellas MH, Simoes F, et al. Cytogenetic analysis of an invasive, poorly differentiated squamous cell carcinomas of the penis. Cancer Genet Cytogenet 1998;101:78-80.
19. Ornellas AA, Ornellas MH, Otero L, et al. Karyotypic findings in two cases of moderately differentiated squamous cell carcinomas of the penis. Cancer Genet Cytogenet 1999;115:77-79.
20. Kersemaekers A-MF, Kenter GG, Hermans J, et al. Allelic loss and prognosis in carcinoma of the uterine cervix. Int J Cancer 1998;79:411-417.
21. Narayan G, Pulido HA, Koul S, et al. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 2003;22:3489-3499.
22. Elhamidi A, Hamoudi RA, Kocjan G, et al. Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci. Gynecol Oncol 2004;94:671-679.
23. Yamamoto N, Mizoe J, Numasawa H, et al. Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Oral Oncol 2003;39:796-805.
24. Kersemaekers AM, van de Vijver MJ, Kenter GG, et al. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes Chromosom Cancer 1999;26:346-354.
25. Tseng RC, Chang JW, Hsien FJ, et al. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer 2005;117:214-217.
26. Foulkes WD, Ragoussis J, Stamp GW, et al. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 1993;67:551-559.
27. Hasina R, Pontier AL, Fekete MJ, et al. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 2006;26:588-598.
28. Garnis C, Coe BP, Ishkanian A, et al. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosom Cancer 2004;39:93-98.
29. Sasiadek M, Stembalska-Kozlowska A, Smigiel R, et al. Microsatellite and chromosome instability in squamous cell laryngeal carcinoma. Int J Oncol 2001;19:401-405.
30. Sasatomi E, Finkelstein SD, Woods JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res 2002;62:2681-2689.
31. Kakinuma N, Kohu K, Sato M, et al. Candidate regions of tumor suppressor gene by loss of heterozygosity analysis on chromosome 8p11.1-q13.3 in gastric cancer. Cancer Lett 2004;213:111-116.
32. Perinchery G, Bukuroy N, Nakajima K, et al. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer. Int J Oncol 1999;14:495-500.
33. Knopp S, Bjorge T, Nesland JM, et al. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. Gynecol Oncol 2004;95:37-45.
34. He XS, Rong YH, Su Q, et al. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance. World J Gastroenterol 2005;11:2218-2223.
35. Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003;201:109-118.
36. Isaksson-Mettavainio M, Palmqvist R, Forssell J, et al. SMAD4/DPC4 expression and prognosis in human colorectal cancer. Anticancer Res 2006;26:507-510.
37. Hirata H, Matsuyama H, Matsumoto H, et al. Deletion mapping of 18q in conventional renal cell carcinoma. Cancer Genet Cytogenet 2005;163:101-105.
38. Baksh FK, Dacic S, Finkelstein SD, et al. Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence. Mod Pathol 2003;16:28-34.
39. Wang D, Fang D, Luo Y, et al. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer. Chin Med Sci J 1999;14:107-111.
40. Carvalho AL, Chuang A, Jinag WW, et al. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 2006;66:9401-9407.
41. Kleist B, Bankau A, Lorenz G, et al. Different risk factors in basaloid and common squamous head and neck cancer. Laryngoscope 2004;114:1063-1068.
42. Choi HR, Roberts DB, Johnigan RH, et al. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol 2004;28:1299-1310.
43. Tonon G, Brennan C, Protopopov A, et al. Common and contrasting genomic profiles among the major human lung cancer subtypes. Cold Spring Harb Symp Quant Biol 2005;70:11-24.
44. Greenawalt DM, Duong C, Smyth GK, et al. Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma. Int J Cancer 2007;120:1914-1921.